A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study † † Presented as oral presentation at ESMO 2012 in Vienna Austria.
Titel:
A randomized phase II study comparing erlotinib versus erlotinib with alternating chemotherapy in relapsed non-small-cell lung cancer patients: the NVALT-10 study † † Presented as oral presentation at ESMO 2012 in Vienna Austria.
Auteur:
Aerts, J.G. Codrington, H. Lankheet, N.A.G. Burgers, S. Biesma, B. Dingemans, A.-M.C. Vincent, A.D. Dalesio, O. Groen, H.J.M. Smit, E.F.